TKMS Analysts Split on What Matters More: Earnings Punch or Cash Cushion

Two broker notes landed on the same day with the same 115-euro price target for TKMS — and a telling disagreement buried inside them. Deutsche Bank lifted its target from 112 to 115 euros and reiterated "Buy," while Bernstein Research trimmed its own from 120 to 115 euros but kept "Outperform." Same number, opposite directions. The gap between them says less about the submarine builder's operating prospects than about how much weight each house puts on the cash side of the ledger.

Deutsche Bank's move was straightforwardly bullish. The analysts expect TKMS to close the 2025/26 fiscal year with a strong showing on both order intake and operating profit. Bernstein's Adrien Rabier is no bear on the business either — he sees quarterly results landing well above market expectations and floats the possibility of an upgrade to the company's medium-term EBIT target.

Yet Rabier cut his target anyway, and the reason was liquidity. Reduced cash assumptions, not doubts about the order book, drove the 5-euro reduction. That distinction matters for anyone reading the two notes side by side: stronger earnings and a more cautious view of available funds can coexist in a single valuation without contradiction.

The Numbers Behind the Optimism

Independent research from mwb research sketches what the bullish case is actually built on. The house, which reaffirmed its buy rating and a 140.00-euro target, projects more than 16% revenue growth for 2025/26 and an adjusted EBIT margin of roughly 6.3%. Both figures are analyst estimates, not company guidance.

The order backlog, meanwhile, is pegged at around 25 billion euros. That is a measure of future business potential — not revenue already booked, and certainly not cash in hand. How those orders convert into operating profit and into liquidity is the question that separates the two 115-euro targets.

Should investors sell immediately? Or is it worth buying TKMS?

Growth tells you how much the business is expanding. The margin tells you what survives after adjustments. Neither, on its own, answers whether the balance sheet can support the valuation multiple.

Why a Good Quarter Might Not Be Enough

The bar for TKMS is unusually high precisely because so much good news is already priced in. A strong result is the baseline expectation, not a surprise. Should the company deliver the beat Rabier anticipates but pair it with liquidity pressure — or with medium-term targets that fall short of the most optimistic assumptions — the shares could struggle to gain traction.

Neither the expected earnings beat nor a potential EBIT target hike is confirmed fact. Investors treating both as given would be front-running an outcome that has yet to be reported. Bernstein's target cut is a useful reminder of that risk: a positive operating view offers no immunity against a more conservative valuation if cash assumptions carry more weight.

The reverse scenario is equally live. If the results impress and management's commentary on financial development reinforces confidence in their quality, the operating strength would rest on firmer ground. An improved medium-term EBIT ambition would extend that story beyond the reporting period — but only if the liquidity picture cooperates.

December 7 Is the Date That Counts

TKMS has scheduled publication of its annual financial report for December 7, 2026. That disclosure is the next hard checkpoint for the growth, margin and backlog expectations mwb research has laid out — and for the cash assumptions Bernstein has trimmed.

For holders, the question is not simply whether TKMS posts good numbers. It is whether those numbers, read alongside the company's financial position, justify a richer valuation. The expected earnings strength will be measured against exactly that standard.

Ad

TKMS Stock: New Analysis - 22 October

Fresh TKMS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated TKMS analysis...